Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial

Watchlist | Portfolio

Ultra Nasdaq Biotechnology 2X ETF (BIB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

ETF Comparison for [[ item.sessionDateDisplayLong ]]

Results

Want to compare other data? Select Fields

Symbol	BIB
Company	Ultra Nasdaq Biotechnology 2X ETF
Price Information
Exchange	NASDAQ
Open	57.47
High	58.10
Low	56.91
Last	58.02
Change	+0.90
% Change	+1.58%
Volume	7,800
20-Day Average Volume	15,335
Previous Close	57.12
Industry	N/A
Has Options	Yes
Technicals
20-Day Moving Average	58.99
20-Day Raw Stochastic	28.32%
20-Day Relative Strength	50.86%
Weighted Alpha	+18.40
Today's Opinion	80% Buy
Previous Opinion	80% Buy
Last Month's Opinion	88% Buy
Performance
5-Days
%Chg	-2.67% since 06/27/24
Low	56.71 on 07/03/24
High	60.84 on 07/01/24
1-Month
%Chg	-2.83% since 06/05/24
Low	56.22 on 06/20/24
High	62.57 on 06/25/24
3-Month
%Chg	+8.45% since 04/05/24
Low	47.19 on 04/19/24
High	62.57 on 06/25/24
6-Month
%Chg	-0.87% since 01/05/24
Low	47.19 on 04/19/24
High	62.57 on 06/25/24
Key Statistics
Market Capitalization, $K	84,129
Shares Outstanding, K	1,450
Annual Sales	0
Annual Net Income	0
Last Quarter Sales	N/A
Last Quarter Net Income	N/A
60-Month Beta	1.63
Per-Share Information
Most Recent Earnings	N/A
Latest Earnings Date	06/27/14
Most Recent Dividend	0.265 on 06/26/24
Next Ex-Dividends Date	06/26/24
Ratios
Price/Earnings ttm	0.00